loading...| Preferred Name |
Amyotrophic lateral sclerosis |
|
| Synonyms |
ALS |
|
| Definitions |
A neurodegenerative disease characterized by progressive muscular paralysis reflecting degeneration of motor neurons in the primary motor cortex, corticospinal tracts, brainstem and spinal cord. |
|
| ID |
http://www.orpha.net/ORDO/Orphanet_803 |
|
| alternative_term |
ALS Lou Gehrig disease Charcot disease |
|
| definition |
A neurodegenerative disease characterized by progressive muscular paralysis reflecting degeneration of motor neurons in the primary motor cortex, corticospinal tracts, brainstem and spinal cord. |
|
| definition_citation |
Orphanet |
|
| expertlink |
https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=803 |
|
| has_age_of_onset |
Adult |
|
| has_inheritance |
Not applicable Autosomal recessive Autosomal dominant |
|
| hasDbXref |
OMIM:617839 OMIM:616208 ICD-10:G12.2 OMIM:615515 OMIM:600795 MeSH:D000690 ICD-11:8B60.0 OMIM:612577 OMIM:606070 OMIM:105400 OMIM:617892 OMIM:613435 OMIM:205250 OMIM:619141 OMIM:608627 OMIM:613954 OMIM:606640 OMIM:619133 MedDRA:10002026 UMLS:C0002736 OMIM:617921 OMIM:612069 OMIM:300857 OMIM:616437 OMIM:611895 OMIM:615426 OMIM:608031 OMIM:608030 OMIM:614808 |
|
| label |
Amyotrophic lateral sclerosis |
|
| notation |
ORPHA:803 |
|
| part_of | ||
| prefixIRI |
ORDO:Orphanet_803 |
|
| prefLabel |
Amyotrophic lateral sclerosis |
|
| present_in |
Uruguay AND has_annual_incidence_average_value : 1.37 AND has_annual_incidence_range : 1-9 / 100 000 Europe AND has_annual_incidence_average_value : 2.2 AND has_annual_incidence_range : 1-9 / 100 000 Worldwide AND has_annual_incidence_average_value : 1.35 AND has_annual_incidence_range : 1-9 / 100 000 United States AND has_annual_incidence_average_value : 1.46 AND has_annual_incidence_range : 1-9 / 100 000 Iran, Islamic Republic of AND has_annual_incidence_average_value : 0.42 AND has_annual_incidence_range : 1-9 / 1 000 000 Italy AND has_annual_incidence_average_value : 3.0 AND has_annual_incidence_range : 1-9 / 100 000 Uruguay AND has_point_prevalence_average_value : 1.9 AND has_point_prevalence_range : 1-9 / 100 000 Taiwan, Province of China AND has_annual_incidence_average_value : 0.51 AND has_annual_incidence_range : 1-9 / 1 000 000 Ireland AND has_annual_incidence_average_value : 2.1 AND has_annual_incidence_range : 1-9 / 100 000 Specific population AND has_point_prevalence_average_value : 6.0 AND has_point_prevalence_range : 1-9 / 100 000 Finland AND has_annual_incidence_average_value : 2.4 AND has_annual_incidence_range : 1-9 / 100 000 Iran, Islamic Republic of AND has_point_prevalence_average_value : 1.57 AND has_point_prevalence_range : 1-9 / 100 000 Spain AND has_point_prevalence_average_value : 5.4 AND has_point_prevalence_range : 1-9 / 100 000 Specific population AND has_annual_incidence_average_value : 1.4 AND has_annual_incidence_range : 1-9 / 100 000 Specific population AND has_annual_incidence_average_value : 2.5 AND has_annual_incidence_range : 1-9 / 100 000 Specific population AND has_point_prevalence_average_value : 10.8 AND has_point_prevalence_range : 1-5 / 10 000 Canada AND has_point_prevalence_average_value : 4.9 AND has_point_prevalence_range : 1-9 / 100 000 Norway AND has_point_prevalence_average_value : 4.0 AND has_point_prevalence_range : 1-9 / 100 000 Denmark AND has_annual_incidence_average_value : 1.4 AND has_annual_incidence_range : 1-9 / 100 000 Taiwan, Province of China AND has_point_prevalence_average_value : 1.97 AND has_point_prevalence_range : 1-9 / 100 000 Faroe Islands AND has_annual_incidence_average_value : 2.6 AND has_annual_incidence_range : 1-9 / 100 000 Finland AND has_point_prevalence_average_value : 6.4 AND has_point_prevalence_range : 1-9 / 100 000 Canada AND has_annual_incidence_average_value : 2.0 AND has_annual_incidence_range : 1-9 / 100 000 United Kingdom AND has_annual_incidence_average_value : 1.06 AND has_annual_incidence_range : 1-9 / 100 000 Norway AND has_annual_incidence_average_value : 2.2 AND has_annual_incidence_range : 1-9 / 100 000 France AND has_annual_incidence_average_value : 2.0 AND has_annual_incidence_range : 1-9 / 100 000 Italy AND has_point_prevalence_average_value : 7.9 AND has_point_prevalence_range : 1-9 / 100 000 Denmark AND has_point_prevalence_average_value : 3.1 AND has_point_prevalence_range : 1-9 / 100 000 Worldwide AND has_point_prevalence_average_value : 3.85 AND has_point_prevalence_range : 1-9 / 100 000 Ireland AND has_point_prevalence_average_value : 4.7 AND has_point_prevalence_range : 1-9 / 100 000 Spain AND has_annual_incidence_average_value : 1.4 AND has_annual_incidence_range : 1-9 / 100 000 United Kingdom AND has_point_prevalence_average_value : 4.9 AND has_point_prevalence_range : 1-9 / 100 000 Europe AND has_point_prevalence_average_value : 5.2 AND has_point_prevalence_range : 1-9 / 100 000 |
|
| treeView | ||
| subClassOf |